维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="Pectasides M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Brain metastases from epithelial ovarian cancer: a review of the literature 显示文摘	Pectasides D Pectasides M Eeonomopoulous T	2006	Oncologist2006，11，：	1
2	Brain metastases from epithelial ovarian cancer:a review of the literature显示文摘	Pectasides D Pectasides M Economopoulos T	2006	Oncologist2006，11，：	1
3	Adjuvant and neo- adjuvant chemotherapy in muscle invasive bladder cancer: lit- erature review显示文摘	Pectasides D Pectasides M Nikolaou M	2005	Eur Urol2005，48，1：	1
4	Determination and biological relevance of serum cross-linked type Ⅰ collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer显示文摘	KANAKIS I NIKOLAOU M PECTASIDES D	2004	Journal of Pharmaceutical and Biomedical Analysis2004，34，4：	1
5	CEA, CA19- 9,and CA- 50 in monitoring gastric carcinoma显示文摘	Pectasides D Mylonalakis A Kostopoulou M	1997	Am J Clin Onco1997，20，4：	1
6	Two cycles of carboplatin based adjuvant chemotherapy for high-risk clinical stage I and stage IM nonseminomatous germ cell tumours of the testis: a HECOG trial显示文摘	Pectasides D Skarlos D Dimopoulos A M	2003	Anticancer Res2003，23，：	1
7	Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase Ⅱ study显示文摘	Pectasides D Pectasides M Farmakis D	2004	Ann Oncol2004，15，3：	1
8	Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase JI study显示文摘	Pectasides D Pectasides M Farmakis D	2004	Eur Urol2004，46，2：	1
9	Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small cell lung cancer:a randomized phase Ⅱ trial显示文摘	Pectasides D Pectasides M Farmakis D	2005	Ann Oncol2005，16，2：	1
10	Molecular profile of head and necksquamous cell carcinomas bearing pl 6 high phe- notype显示文摘	Rampias T Pectasides E Prasad M	2013	Ann Oncoi2013，24，8：	1
11	Systemic chemotherapy in locally advanced and/or metastatic bladder cancer 显示文摘	Pectasides D Pectasides M Economopoulos T	2006	Cancer Treat Rev2006，32，6：	1
12	CEA, CA19 -9 and CA50 in monitoring gastric carcinoma显示文摘	Pectasides D Myloanlakis A Kostopouiou M	1997	Am J Clin Oncol1997，20，4：	1
13	Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer显示文摘	Pectasides D Farmakis D Nikolaou M	2005	J Pharm Biomed Anal2005，37，1：	1
14	Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid显示文摘	Nikolaou M Farmakis D	2005	Anticancer Res2005，25，2：	1
15	CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma 显示文摘	Pectasides D Mylonakis A Kostopoulou M	1997	Am J Clin Oncol1997，20，4：	1
16	Oxaliplatin and irinoteean plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase Ⅱ study显示文摘	Pectasides D Pectasides M Farmakis D	2004	Eur Urol2004，46，2：	1
17	Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors显示文摘	Farmakis D Pectasides M Pectasides D		0，，03：	1
18	Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer显示文摘	PECTASIDES D FARMAKIS D NIKOLAOU M	2005	J Pharm Biomed Anal2005，37，1：	1
19	Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase Ⅱ study显示文摘	Pectasides M Farmakis D	2003	Ann Oncol2003，14，4：	1
20	CEA, CA19-9 and CA-50 in monitoring gastric carcinoma显示文摘	Pectasides D Myloanlakis A Kostopouiou M	1997	Am J Clin Oncol1997，20，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示